Coarctation Of the Aorta Stent Trial

Key facts

Sponsor

Richard E. Ringel

Principal Investigator

Richard E Ringel, MD

Johns Hopkins University

Intervention

Stent therapy of aortic coarctation(device)

Enrollment

105 enrolled

Eligibility

8-60 years · All sexes

Timeline

2007 – 2015

Study locations (1)

• Children's Hospital Boston, Boston, Massachusetts, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for OBSOLETE: Autosomal dominant coarctation of aorta

Additional recruiting or active studies for the same condition.

• ENROLLING BY INVITATIONNCT07134621
  Target Organ Damage in Patients With Repaired Coarctation of Aorta and Exercise Induced Hypertension
  University Medical Centre Ljubljana
• RECRUITINGNANCT07316855
  Evaluating the Feasibility of Bioresorbable Iron-Based Covered Stent: A Clinical Trial
  Shubo Song
• ENROLLING BY INVITATIONNCT05880576
  The Arch Watch Study: An Integrated Evaluation of Hemodynamics in Infants With Suspected Coarctation of the Aorta
  Boston Children's Hospital
• RECRUITINGNCT06759103
  Electronic Archive of Patients With Diagnosis and Suspected Prenatal Diagnosis of Aortic Coarctation
  IRCCS Azienda Ospedaliero-Universitaria di Bologna
• ACTIVE NOT RECRUITINGNANCT05086016
  Growth Trial: Study of the Renata Minima Stent
  Renata Medical
• ACTIVE NOT RECRUITINGNCT05362721
  PV Loop & Coarctation Study
  University of Minnesota

See all trials for OBSOLETE: Autosomal dominant coarctation of aorta →